Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity
- PMID: 20111911
- DOI: 10.1007/s12022-009-9105-z
Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity
Abstract
Growth hormone (GH)-producing pituitary adenomas have been classified into densely and sparsely granulated adenomas. The latter are chromophobic with weak GH-positivity and characteristically possess fibrous body (FB), aggregation of cytokeratin filaments. We report eight cases of unusual chromophobic adenomas. GH-immunoreactivity was detected in most adenoma cells in five cases and scattered in three cases. However, it appeared much weaker than that seen in ordinary GH-producing adenomas because of spotty immunoreactivity. Although intracytoplasmic organelles were well-developed, secretory granules were small and sparse. FB was not identified in any cases. Thyroid-stimulating hormone was positive in four cases. Pit-1 protein was positive in all eight cases. A weak labeling with GH probe was detected in two of two cases examined by in situ hybridization. Acromegalic features were evident in four cases, while mild or absent in four cases. GH levels were below 5 microg/l in four cases and 5-10 microg/l in the remaining cases. Macroadenomas and invasive adenomas were seen in seven and six cases, respectively.Pituitary adenomas that show a faint GH-immunoreactivity but lack FB do not fit the established classification. These adenomas may be a distinct pituitary adenoma type of Pit-1 lineage with endocrinologically low activity.
Similar articles
-
Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.Endocr Pathol. 2008 Summer;19(2):82-91. doi: 10.1007/s12022-008-9029-z. Endocr Pathol. 2008. PMID: 18629656
-
Morphological characterization and subtyping of silent somatotroph adenomas.Pituitary. 1999 May;1(3-4):233-41. doi: 10.1023/a:1009942122673. Pituitary. 1999. PMID: 11081203
-
Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.Virchows Arch A Pathol Anat Histopathol. 1993;422(3):193-201. doi: 10.1007/BF01621802. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 8493775
-
Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas.Front Horm Res. 2004;32:127-32. doi: 10.1159/000079041. Front Horm Res. 2004. PMID: 15281343 Review.
-
Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?Pituitary. 1999 May;1(3-4):269-71. doi: 10.1023/a:1009954409469. Pituitary. 1999. PMID: 11081207 Review.
Cited by
-
Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas.Endocr Pathol. 2012 Sep;23(3):151-6. doi: 10.1007/s12022-012-9208-9. Endocr Pathol. 2012. PMID: 22569896
-
Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.ISRN Endocrinol. 2013;2013:723432. doi: 10.1155/2013/723432. Epub 2013 Jan 21. ISRN Endocrinol. 2013. PMID: 23401791 Free PMC article.
-
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.Pituitary. 2021 Apr;24(2):192-206. doi: 10.1007/s11102-020-01096-2. Epub 2020 Oct 19. Pituitary. 2021. PMID: 33074402
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical